ISSN (Print): 2328-7314

ISSN (Online): 2328-7322


Editor-in-chief: Nabil Abdel-Hamid

You are here

Currrent Issue: Volume 5, Number 1, 2017


Extranuchal-type Fibroma Mimicking Low Grade Sarcoma: A Case Report and Review of the Literature

1Molecular Pathology Research Center, Emam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran

2Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran

American Journal of Cancer Prevention. 2017, 5(1), 17-20
doi: 10.12691/ajcp-5-1-3
Copyright © 2017 Science and Education Publishing

Cite this paper:
Mazaher Ramezani, Marziyeh Masnadjam, Masoud Sadeghi. Extranuchal-type Fibroma Mimicking Low Grade Sarcoma: A Case Report and Review of the Literature. American Journal of Cancer Prevention. 2017; 5(1):17-20. doi: 10.12691/ajcp-5-1-3.

Correspondence to: Masoud  Sadeghi, Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran. Email:


Nuchal-type fibroma (NTF) is a rare fibrous growth that developing in the nuchal region, in some instances it occurs at the extranuchal sites. Herein, this study reported a case of NTF on extranuchal site in an Iranian girl in Western Iran. The report included a 14-year-old girl with a chief complaint of right hemithorax suprascapular soft tissue mass since 6 years ago and tenderness since last month that physical examination showed firm, tender, non-erythematous mass measuring 5x10 cm with adhesion to surrounding tissue was noted on the right hemithorax over the scapula. Frozen section diagnosis showed spindle cell tumor compatible with low grade sarcoma, but the pathologist reported an extranuchal-type fibroma in permanent. In conclusion, NTF occurs more frequently in middle-aged adults and is more common in men. The prevalence of nuchal region is more than extranuchal region in NTF patients. The NTF is associated with trauma more than Gardner’s syndrome. Also, the pathologist and surgeon must be aware of this entity, especially at extranuchal sites, not to be misinterpreted as sarcoma.



[1]  Diwan AH, Graves ED, King JA, Horenstein MG. Nuchal-type fibroma in two related patients with Gardner's syndrome. Am J Surg Pathol. 2000; 24(11): 1563-7.
[2]  Enzinger FM, Weiss SW. Benign Tumors and Tumorlike Lesions of the Fibrous Tissue, 2nd C.V. Mosby, St. Louis, MO. 1988: 102-35.
[3]  Lee GK, Suh KJ, Lee SM, Lee SJ. Nuchal-type fibroma of the buttock: magnetic resonance imaging findings. Jpn J Radiol. 2010; 28(7): 538-41.
[4]  Kim DH, Kim TH, Sung NH, Shin H, Lee AY, Lee SH. Multiple nuchal-type fibromas on the scalp: a case report. Ann Dermatol. 2015; 27(2): 194-6.
[5]  Gong Y, Zhao X, Wu DI, Liu J. Nuchal-type fibroma of the shoulder: A case report and review of the literature. Oncol Lett. 2016; 11(6): 4152-4.
Show More References
[6]  Abe M, Nagai Y, Okada E, Aoyama K, Tamura A, Ishikawa O. Case of nuchal fibroma. J Dermatol. 2007; 34(7): 498-500.
[7]  Linos K, Sedivcová M, Cerna K, Sima R, Kazakov DV, Nazeer T, et al. Extra nuchal-type fibroma associated with elastosis, traumatic neuroma, a rare APC gene missense mutation, and a very rare MUTYH gene polymorphism: a case report and review of the literature. J Cutan Pathol. 2011; 38(11): 911-8.
[8]  Michal M, Fetsch JF, Hes O, Miettinen M. Nuchal-type fibroma: a clinicopathologic study of 52 cases. Cancer. 1999;85(1):156-63.
[9]  Shin JB, Son SW, Kim IH. Nuchal-type fibroma of the coccyx. Ann Dermatol.2008; 20(1): 41-4.
[10]  Sraj SA, Lahoud LE, Musharafieh R, Taha A. Nuchal-type fibroma of the ankle: a case report. J Foot Ankle Surg. 2008; 47(4): 332-6.
[11]  Karonidis A, Rigby HS, Orlando A. Collagenosis nuchae: a case report of a rare and often misdiagnosed condition. J Plast Reconstr Aesthet Surg. 2007; 60(3): 320-3.
[12]  Banney L, Weedon D, Muir J. Nuchal fibroma associated with scleredema, diabetes mellitus and organic solvent exposure. Australas J Dermatol. 2000; 41(1): 39-41.
[13]  Diwan AH, Horenstein MG. Dermatofibrosarcoma protuberans association with nuchal-type fibroma. J Cutan Pathol. 2004; 31(1): 62-6.
[14]  Tsunemi Y, Saeki H, Tamaki K. Nuchal fibroma clearly visualized by computed tomography: a case report. Int J Dermatol. 2005; 44(8): 703-4.
[15]  Alsaleh N, Amanguno H. Nuchal Fibroma : A rare entity of neck masses. Gulf J Oncolog. 2015; 1(18): 10-2.
[16]  Hameed M, Benevenia J, Blacksin M, Aisner SC. Nuchal fibroma of the shoulder involving skeletal muscle: a radiographic and clinicopathological study. A case report. J Bone Joint Surg Am. 1998; 80(11): 1684-6.
[17]  Lee SE, Kim YC, Kim SC. Nuchal fibroma presenting as two posterior neck masses. J Dermatol. 2007; 34(4): 262-3.
[18]  Yokoyama S, Nakano H, Kaneko T, Hanada K. A Japanese case of nuchal-type fibroma. J Dermatol. 2005; 32(11): 931-2.
[19]  Lee CC, Lai CS, Lin CH, Lin YN, Chu SC, Chai CY, et al. Extra nuchal-type fibroma associated with repetitive blunt trauma during religious activities. Trauma Case Reports.2016; 4: 16-20.
[20]  Balachandran K, Allen PW, MacCormac LB. Nuchal fibroma. A clinicopathological study of nine cases. Am J Surg Pathol. 1995; 19(3): 313-7.
Show Less References


Knowledge and Awareness about Cervical Cancer Screening and HPV Vaccine among Females Aged 15-49 Years in Rukum District of Nepal

1EPI, District Health Office, Rukum, Nepal

2Department of Health Sciences, National Open College, Pokhara University, Sanepa, Lalitpur, Nepal

3Department of Public Health, Asian College for Advance Studies, Lalitpur, Nepal

4Department of Biostatistics, KS Hegde Medical Academy, Nitte University, Mangalore, India

5Department of Research & Development, National Open College, Pokhara University, Sanepa, Lalitpur, Nepal

6Integrated management of Acute Malnutrition, IRHDTC, Maharajgunj, Nepal

7Nepal Cancer Care Foundation, Lalitpur, Nepal

American Journal of Cancer Prevention. 2017, 5(1), 10-16
doi: 10.12691/ajcp-5-1-2
Copyright © 2017 Science and Education Publishing

Cite this paper:
Krishna Khadka, Sanjeev Kumar Shah, Sanal TS, Jennifer Mathias, Abinash Upadhayay, Raju Ghimire, Sarita Ghimire. Knowledge and Awareness about Cervical Cancer Screening and HPV Vaccine among Females Aged 15-49 Years in Rukum District of Nepal. American Journal of Cancer Prevention. 2017; 5(1):10-16. doi: 10.12691/ajcp-5-1-2.

Correspondence to: Sanjeev  Kumar Shah, Department of Health Sciences, National Open College, Pokhara University, Sanepa, Lalitpur, Nepal. Email:;


Introduction: Cervical cancer is the first most common cancer and the leading cause of mortality among women in Nepal. The annual age standardized incidence rate of cervical cancer is 19.0 and the mortality rate is 12.0 per 100,000 women. Awareness and knowledge about cervical cancer among females is essential in the prevention of cancer. The objective of this study was to assess the level of knowledge and awareness about cervical cancer and to identify the screening practices among the women in Rukum district of Nepal. Methodology: This cross sectional study was conducted in Jan to Feb 2016 in Rukum, Nepal. Multistage sampling technique was used and 600 Female aged between 15-49 years were recruited. A semi structured interview questionnaire was used to collect the information. The inferential statistics, chi square test was used to summarize the data. For bivariate analysis, odds ratio and its 95% CI were obtained and binary logistic regression technique was used as a multivariate analysis. Results: Among the 600 women, 77.5% had heard about cervical cancer. Of these only 16% (72) were aware about cervical cancer screening and 7% were aware about the Pap smear test. Among these only 13.6 % (8/72) had ever undergone for cervical cancer screening. Only 5% had heard about HPV, among of them 30% knew that it can cause cervical cancer. Only 47% had adequate knowledge about cervical cancer, HPV and its screening. Education, occupation and monthly household income of the participants were significantly associated with knowledge of cervical cancer. Conclusion: This study identified that, there have been a low level of knowledge about cervical cancer among women. It indicates that there is a need to implement some strategies to enhance the knowledge of cervical cancer for these women.



[1]  Feraly J, Soerijomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0,Cancer Incidence and Mortality worldwide: IARC Cancer Base No 11.Lyon,France:International Agency for Research on Cancer;2013. [Accessed on 2nd Sep 2015]. Available from:
[2]  Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012: Global Cancer Statistics, 2012. CA Cancer J Clin. 2015 Mar;65(2):87-108.
[3]  World Health Organization. Comprehensive cervical cancer prevention and control: a healthier future for girls and women. Geneva, Switzerland: World Health Organization Press. 2013. Available from:
[4]  Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003 Jan; 16(1):1-17.
[5]  Castellsagué X, Muñoz N. Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr. 2003; (31): 20-8.
Show More References
[6]  Ribeiro AA, Costa MC, Alves RRF, Villa LL, Saddi VA, Carneiro MADS, et al. HPV infection and cervical neoplasia: associated risk factors. Infect Agent Cancer. 2015; 10: 16.
[7]  Bruni L, Barrionuevo-Rosas L, Albero G, et al. ICO information Centre on HPV and Cancer (HPV Information Centre).Human Papillomavirus and Related Diseases in Nepal. Summary Report 2015. [Accessed on 2nd Sep 2015]. Available from:
[8]  World Health Organization, World Health Organization, Reproductive Health and Research. Comprehensive cervical cancer control: a guide to essential practice. [Internet]. 2014 [cited 2015 Nov 1]. Available from:
[9]  Control of cancer of the cervix uteri. A WHO meeting. Bull World Health Organ. 1986; 64(4): 607-18.
[10]  Gakidou E, Nordhagen S, Obermeyer Z. Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. PLoS Med. 2008 Jun 17; 5(6): e132.
[11]  Johnson DC, Bhatta MP, Gurung S, Aryal S, Lhaki P, Shrestha S. Knowledge and awareness of human papillomavirus (HPV), cervical cancer and HPV vaccine among women in two distinct Nepali communities. Asian Pac J Cancer Prev APJCP. 2014; 15(19): 8287-93.
[12]  Liu FW, Vwalika B, Hacker MR, Allen S, Awtrey CS. Cervical cancer and HPV vaccination: Knowledge and attitudes of adult women in Lusaka, Zambia. J Vaccines Vaccin. 2012 Jun 12; 3(138).
[13]  Ugwu E, Obi S, Ezechukwu P, Okafor I, Ugwu A. Acceptability of human papilloma virus vaccine and cervical cancer screening among female health-care workers in Enugu, Southeast Nigeria. Niger J Clin Pract. 2013; 16(2):249.
[14]  Ortashi O, Raheel H, Shalal M, Osman N. Awareness and knowledge about human papillomavirus infection and vaccination among women in UAE. Asian Pac J Cancer Prev APJCP. 2013; 14(10): 6077-80.
[15]  Sabeena S, Bhat PV, Kamath V, Aswathyraj S, Arunkumar G. Knowledge, Attitude and Practice Concerning Human Papilloma Virus Infection and its Health Effects among Rural Women, Karnataka, South India. Asian Pac J Cancer Prev APJCP. 2015; 16(12): 5053-8.
[16]  Bansal AB, Pakhare AP, Kapoor N, Mehrotra R, Kokane AM. Knowledge, attitude, and practices related to cervical cancer among adult women: A hospital-based cross-sectional study. J Nat Sci Biol Med. 2015 Dec; 6(2): 324-8.
[17]  Joy T, Sathian B, Bhattarai C, Chacko J. Awareness of cervix cancer risk factors in educated youth: a cross-sectional, questionnaire based survey in India, Nepal, and Sri Lanka. Asian Pac J Cancer Prev APJCP. 2011; 12(7): 1707-12.
[18]  Saha A, Chaudhury AN, Bhowmik P, Chatterjee R. Awareness of cervical cancer among female students of premier colleges in Kolkata, India. Asian Pac J Cancer Prev APJCP. 2010; 11(4): 1085-90.
[19]  Assoumou SZ, Mabika BM, Mbiguino AN, Mouallif M, Khattabi A, Ennaji MM. Awareness and knowledge regarding of cervical cancer, Pap smear screening and human papillomavirus infection in Gabonese women. BMC Womens Health. 2015; 15: 37.
[20]  Ozyer S, Uzunlar O, Ozler S, Kaymak O, Baser E, Gungor T, et al. Awareness of Turkish female adolescents and young women about HPV and their attitudes towards HPV vaccination. Asian Pac J Cancer Prev APJCP. 2013; 14(8): 4877-81.
[21]  Cunningham MS, Skrastins E, Fitzpatrick R, Jindal P, Oneko O, Yeates K, et al. Cervical cancer screening and HPV vaccine acceptability among rural and urban women in Kilimanjaro Region, Tanzania. BMJ Open. 2015; 5(3): e005828.
[22]  Shrestha J, Saha R, Tripathi N. Knowledge, Attitude and Practice regarding Cervical Cancer Screening Amongst Women visiting Tertiary Centre in Kathmandu, Nepal. Nepal J Med Sci. 2013 Oct 14; 2(2): 85-90.
[23]  Ranabhat S, Tiwari M, Dhungana G, Shrestha R. Association of knowledge, attitude and demographic variables with cervical Pap smear practice in Nepal. Asian Pac J Cancer Prev APJCP. 2014; 15(20): 8905-10.
[24]  Shekhar S, Sharma C, Thakur S, Raina N. Cervical Cancer Screening: Knowledge, Attitude and Practices among Nursing Staff in a Tertiary Level Teaching Institution of Rural India. Asian Pac J Cancer Prev. 2013 Jun 30;14(6):3641-5.
[25]  Hoque ME, Ghuman S, Hal GV. Human Papillomavirus vaccination acceptability among female university students in South Africa. Asian Pac J Cancer Prev APJCP. 2013; 14(8): 4865-9.
[26]  Ebu NI, Mupepi SC, Siakwa MP, Sampselle CM. Knowledge, practice, and barriers toward cervical cancer screening in Elmina, Southern Ghana. Int J Womens Health. 2015; 7: 31-9.
[27]  Kim Y, Jun JK, Choi KS, Lee H-Y, Park E-C. Overview of the National Cancer screening programme and the cancer screening status in Korea. Asian Pac J Cancer Prev APJCP. 2011; 12(3): 725-30.
[28]  Sirovich BE, Welch HG. The Frequency of Pap Smear Screening in the United States. J Gen Intern Med. 2004 Mar 1; 19(3): 243-50.
Show Less References


Experience for Management of Surgical Treatment in Patients with Carcinomas of the Pancreatic Head or Periampullary Region

1Department of General Surgery Hospital of traditional Chinese medicine of Yubei, Chongqing, 401120, China

2Department of Hepatobiliary Surgery, the Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China

American Journal of Cancer Prevention. 2017, 5(1), 1-9
doi: 10.12691/ajcp-5-1-1
Copyright © 2017 Science and Education Publishing

Cite this paper:
LUO Tao, LI Xing, GONG Jianping, LI Qujin. Experience for Management of Surgical Treatment in Patients with Carcinomas of the Pancreatic Head or Periampullary Region. American Journal of Cancer Prevention. 2017; 5(1):1-9. doi: 10.12691/ajcp-5-1-1.

Correspondence to: LI  Qujin, Department of Hepatobiliary Surgery, the Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China. Email:


Objective: Pancreaticoduodenectomy was considered as the standard choice of surgery treatment to carcinomas in the pancreatic head or periampullary region. This study will focus on the experience summary to manage the patients with carcinomas in the pancreatic head or periampullary region who underwent surgery treatment in west area of China to investigate the different surgical methods, prognosis and long term survival. Method: We consecutively reviewed 73 patients underwent surgery treatment in our hospital between January 2007 and December 2011. Surgery treatment described as radical operation of PD treatment and palliative operation of choledochojejunostomy plus drainage. We assessed different variables to summarize the management of patients and to evaluate the long term survival. Result: 32 patients received PD treatment and 41 patients received palliative surgery treatment. Histologic diagnosis indicated that all patients had malignant disease. PD procedures spent more time to complete the operation. 3 patients in PD group developed pancreatic fistula and 1 of them died on the seventh days postoperative. 2 patients developed wound infection and 1 patient developed malnutrition which finally reversed by medical intervention. The postoperative mortality in PD group was observed in 2 of 32 patients. The postoperative mortality in PD group was 6.25% (n=2). Long term survival of PD and palliative surgery group was described as 15.4 months and 5.6 months respectively. Conclusion:The treatment of patients with carcinomas in the pancreatic head or periampullary region continues to be associated with high incidence of postoperative complicatons. Early diagnosis and pancreaticoduodenectomy represents the only possibility of cure.



[1]  Schmidt C Max, Powell Emilie S, Yiannoutsos Constantin T, et al. Pancreaticoduodenectomy a 20-year experience in 516 patients. Arch Surg, 2004; 139: 718-725.
[2]  Lai EC. H, Lau SH. Y, Lau WY. Measures to prevent pancreatic fistula after Pancreatoduodenectomy. Arch Surg. 2009, 144: 1074-1080.
[3]  Kong Justin, Gananadha Sivakumar, Hugh TJ, et al. pancreaticoduodenectomy: role of drain fluid analysis in the management of pancreatic fistula. Anz J. Surg, 2008; 78: 240-244.
[4]  Fuks David, Piessen Guillaume, Huet Emmanuel, et al. Life-threatening postoperativepancreatic fistula (grade C) after pancreaticoduodenectomy: incidence, prognosis, and risk factors. Am J Surg, 2009; 197: 702-709.
[5]  PatrikPessaux, Alain Sauvanet, Christophe Mariette, et al. External pancreatic duct stent decreases pancreatic fistula rate after pancreaticoduodenectomy: prospective multicenter randomized trial. Ann Surg, 2011; 253: 879-855.
Show More References
[6]  Weitz J, Rahbari N, Koch M, et al. The “artery first” approach for resection of pancreatic head cancer. J Am Coll Surg. 2010; 210:e1-4.
[7]  Gaedcke J, Gunawan B, Grade M, et al. The meso-pancreas is the primary site for R1 resection in pancreatic head cancer: relevance for clinical trials. Langenbecks Arch Surg. 2010, 395: 451-8.
[8]  Petrou A1, Soonawalla Z, Silva MA, at al. Prognostic indicators following curative pancreatoduodenectomy for pancreatic carcinoma: A retrospective multivariate analysis of a single centre experience. J BUON. 2016 Jul-Aug; 21(4):874-882.
[9]  Xu HX, Liu L, Xiang JF, et al. Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outcomes of pancreatic ductal adenocarcinoma. Surgery. 2016 Nov 9. [Epub ahead of print].
[10]  Van der Gaag, Rauws Erik A.J, Van Eijck Casper H, et al. Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med 2010; 362: 129-137.
[11]  Eshuis Wietse J, Van Der Gaag N A, Rauws Erik A, et al. Therapeutic delay and survival after surgery for cancer of the pancreatic head with or without preoperative biliary drainage. Annals of Surg 2010; 252: 840-849.
[12]  Pannala Rahul, Leirness Jeffery, Bamlet William R, et al. Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology 2008; 134: 981-987.
[13]  Olivié Damien, Lepanto Luigi, Billiard Jean Sébastien, et al. Predicting resectability of pancreatic head cancer with multi-detector CT. Surgical and pathologic correlation. JOP 2007; 8: 753-758.
[14]  Hidalgo Manuel. Pancreatic cancer. N Eng J Med 2010; 362: 1605-1617.
[15]  De Jong Mechteld C, Farnell Michael B, Sclabas Guido, et al. Liver-directed therapy for hepatic metastases in patients undergoing pancreaticoduodenectomy. Ann Surg 2010; 252: 142-148.
[16]  Haga Yoshio, Wada Yasuo, Takeuchi Hitoshi, et al. Prediction of anastomotic leak and its prognosis in digestive surgery. World J Surg 2011; 35: 716-722.
[17]  Kawai Manabu, Yamaue Hiroki. Analysis of clinical trials evaluating complications after pancreaticoduodenectomy: a new era of pancreatic surgery. Surg Today, 2010; 40: 1011-1017.
[18]  Wu W, Wang X, Wu X, et al. Total mesopancreas excision for pancreatic head cancer: analysis of 120 cases. Chin J Cancer Res. 2016 Aug; 28(4):423-8.
[19]  Chu Carrie K, Farnell Michael B, Nguyen Justin H, et al. Prosthetic graft reconstruction after portal vein resection in pancreaticoduodenectomy: a multicenter analysis. J Am CollSurg 2010; 211: 316-324.
[20]  Chua Terence C, Saxena Akshat. Extended pancreaticoduodenectomy with vascular resection for pancreatic cancer: a systematic review. J Gastrointest Surg, 2010; 14: 1442-1452.
[21]  Xu Yufei, Liu Zuojin, Gong Jianping. Pancreaticoduodenectomy with early superior mesenteric artery dissection. Hepatobiliary Pancreat Dis Int. 2010, 9: 579-583.
[22]  Lin Q, Tan L, Zhou Y, et al. Radical nerve dissection for the carcinoma of head of pancreas: report of 30 cases. Chin J Cancer Res. 2016 Aug; 28(4):429-34.
[23]  Fujioka S, Misawa T, Yanaga K. Isolating tape method is useful for an early judgment of curability during pancreaticoduodenectomy forpancreatic cancer. J Hepatobiliary Pancreat Sci. 2016 Oct; 23(10): 20-24.
[24]  Yan L, Siddiqui AA, Laique S, et al. A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas. Minerva Gastroenterol Dietol. 2016 Nov 8. [Epub ahead of print]
[25]  Werner Hartwig, Thilo Hackert, Ulf Hinz, et al. Pancreatic cancer surgery in the new millennium better prediction of outcome. Ann Surg 2011; 254: 311-319.
[26]  Katz Matthew H G, Merchant Nipun B, Brower Steven, et al. Standardization of surgical and pathologic variables is needed in multicenter trials of adjuvant therapy for pancreatic cancer: results from the ACOSOG Z5031 trial. Ann Surg Oncol, 2011; 18: 337-344.
Show Less References